• H Harding, A Broom, and J Broom.
• Sunshine Coast Hospital and Health Service, Queensland, Australia. Electronic address: henry.harding@health.qld.gov.au.
• J. Hosp. Infect. 2020 Aug 1; 105 (4): 717-725.

AbstractThe transmission behaviour of severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) is still being defined. It is likely that it is transmitted predominantly by droplets and direct contact and it is possible that there is at least opportunistic airborne transmission. In order to protect healthcare staff adequately it is necessary that we establish whether aerosol-generating procedures (AGPs) increase the risk of transmission of SARS-CoV-2. Where we do not have evidence relating to SARS-CoV-2, guidelines for safely conducting these procedures should consider the risk of transmitting related pathogens. Currently there is very little evidence detailing the transmission of SARS-CoV-2 associated with any specific procedures. Regarding AGPs and respiratory pathogens in general, there is still a large knowledge gap that will leave clinicians unsure of the risk to themselves when offering these procedures. This review aimed to summarize the evidence (and gaps in evidence) around AGPs and SARS-CoV-2.Copyright © 2020 The Healthcare Infection Society. All rights reserved.

27 keywords...

hide…